Reporting owner · CIK 0001190279

Rodriguez Raul R

Visual SEC Form 4 history across 1 companies, 17 transactions and 6 filings.

CEO, PRESCEO, PresidentRIGEL PHARMACEUTICALS INC
Open-market mix
Latest filingSep 03, 2026, 10:59 PM
Filings6Form 4 records
Buying$00 purchases
Selling$200.1K2 sales
Net value−$200.1KBuys minus sells
Companies13 securities
Most recentSep 01, 2026withholding

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-5Jan 252Feb 25Jan 26Feb 26Sep 26

Net value flow

Buys minus sells

Jan 25
$0
Feb 25
−$200.1K
Jan 26
$0
Feb 26
$0
Sep 26
$0

Transaction texture

Ownership and ticket size

Average P/S size$100K
Median P/S size$100K
Direct17
Indirect0
Sep 01, 2026withholding

Filing-only signals

Deterministic matches in this insider's history

Cluster Sellingpattern2Delayed Filingfiling-context5Derivative Transactionfiling-context3Direct Ownershipfiling-context16Large Holdings Increaseholdings1Repeat Sellerpattern1

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at RIGEL PHARMACEUTICALS INC on Feb 05, 2025 valued at $96,474.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at RIGEL PHARMACEUTICALS INC on Feb 05, 2025 valued at $96,474.

Review SEC filing

Associated companies

Visual map of known reporting history

RIGLRIGEL PHARMACEUTICALS INC17 transactions · latest Sep 03, 2026, 10:59 PM
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
RIGLRODRIGUEZ RAUL R
CEOPRES
withholding2.42k-$11.5MF
Direct Ownership
0.0%09/0309/01
RIGLRODRIGUEZ RAUL R
CEOPRES
grant53.9k$0A
Direct Ownership
−21.3%02/1902/17
RIGLRODRIGUEZ RAUL R
CEOPRES
exercise40.0k$0M
Delayed Filing Derivative Transaction Direct Ownership
−19.6%02/0401/26
RIGLRODRIGUEZ RAUL R
CEOPRES
withholding14.1k-$50.8MF
Direct Ownership
−19.6%02/0402/02
RIGLRODRIGUEZ RAUL R
CEOPRES
withholding35.4k-$131MF
Delayed Filing Direct Ownership
−19.6%02/0401/26
RIGLRODRIGUEZ RAUL R
CEOPRES
exercise40.0k$109MM
Delayed Filing Direct Ownership
−19.6%02/0401/26
RIGLRODRIGUEZ RAUL R
CEOPRES
withholding35.2k-$130MF
Delayed Filing Direct Ownership
−19.6%02/0401/26
RIGLRODRIGUEZ RAUL R
CEOPRES
exercise40.0k$109MM
Delayed Filing Direct Ownership
−19.6%02/0401/26
RIGLRODRIGUEZ RAUL R
CEOPRES
sale4.40k-$9.64MS
Cluster Selling Direct Ownership Repeat Seller
—02/07/202502/05/2025
RIGLRODRIGUEZ RAUL R
CEOPRES
sale4.95k-$10.3MS
Cluster Selling Direct Ownership
—02/07/202502/04/2025

Rodriguez Raul R Insider Activity FAQ

SEC Form 4 context

Who is Rodriguez Raul R?

Rodriguez Raul R is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001190279.

Which companies has Rodriguez Raul R reported transactions for?

RIGEL PHARMACEUTICALS INC

When was Rodriguez Raul R's latest insider buy?

No open-market insider purchase is available for this period.

When was Rodriguez Raul R's latest insider sale?

sale at RIGEL PHARMACEUTICALS INC on Feb 05, 2025 valued at $96,474.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.